Methotrexate injection: An old drug with a newly developing landscape
Int J Rheum Dis
.
2023 Dec;26(12):2366-2370.
doi: 10.1111/1756-185X.14879.
Authors
Ning Tan
1
,
Chi-Jen Hsu
2
,
Han-You Mo
3
,
Xiuyan Yang
1
4
5
,
James Cheng-Chung Wei
6
7
8
9
Affiliations
1
Department of Traditional Chinese Medicine and Rheumatology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China.
2
Department of Orthopedics, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
3
Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
4
Department of Rheumatology and Immunology, Guangdong Clifford Hospital, Guangzhou, China.
5
Department of Rheumatology and Immunology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
6
Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
7
Department of Nursing, Chung Shan Medical University, Taichung, Taiwan.
8
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
9
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
PMID:
38041651
DOI:
10.1111/1756-185X.14879
No abstract available
Publication types
Editorial
MeSH terms
Humans
Methotrexate* / administration & dosage
Methotrexate* / therapeutic use
Substances
Methotrexate